If you liked this article you might like

Takeaways and Observations; What's Driving My Approach: Doug Kass' Views
Good, the Bad and the Ugly; What Troubles Me: Doug Kass' Views
Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports
Celgene Has Loads of Potential